Literature DB >> 7262176

Disposition of azapropazone in chronic renal and hepatic failure.

K H Breuing, H J Gilfrich, T Meinertz, U W Wiegand, E Jähnchen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7262176     DOI： 10.1007/BF00607152

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  21 in total

1.  Pharmacokinetics of drugs in patients with the nephrotic syndrome.

Authors:  R Gugler; D W Shoeman; D H Huffman; J B Cohlmia; D L Azarnoff
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

2.  [Clinical efficacy of the new anti-inflammatory agent Azapropazone].

Authors:  H Sausgruber
Journal:  Arzneimittelforschung       Date:  1971-08

3.  [Azapropazone plasma levels in rheumatologic therapy with D-penicillamine combined with immunosuppressive agents].

Authors:  G Faust-Tinnefeldt; H E Geissler; E Mutschler
Journal:  Arzneimittelforschung       Date:  1977

4.  The effect of indomethacin on proteinuria and kidney function in the nephrotic syndrome.

Authors:  L Arisz; A J Donker; J R Brentjens; G K van der Hem
Journal:  Acta Med Scand       Date:  1976

Review 5.  Azapropazone - its place in the management of rheumatoid conditions.

Authors:  P M Brooks; W W Buchanan
Journal:  Curr Med Res Opin       Date:  1976       Impact factor: 2.580

6.  Plasma protein binding of azapropazone in patients with kidney and liver disease.

Authors:  E Jähnchen; K J Blanck; K H Breuing; H J Gilfrich; T Meinertz; D Trenk
Journal:  Br J Clin Pharmacol       Date:  1981-04       Impact factor: 4.335

7.  [On the determination of azapropazone from plasma by direct quantitative thin-layer chromatography (author's transl)].

Authors:  H E Geissler; E Mutschler; G Faust-Tinnefeldt
Journal:  Arzneimittelforschung       Date:  1977

8.  Aspirin-induced depression of renal function.

Authors:  R P Kimberly; P H Plotz
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

9.  Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.

Authors:  R D Zipser; J C Hoefs; P F Speckart; P K Zia; R Horton
Journal:  J Clin Endocrinol Metab       Date:  1979-06       Impact factor: 5.958

10.  Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.

Authors:  T D Boyer; P Zia; T B Reynolds
Journal:  Gastroenterology       Date:  1979-08       Impact factor: 22.682
View more
  3 in total

Review 1.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

Review 2.  Protein binding as a primary determinant of the clinical pharmacokinetic properties of non-steroidal anti-inflammatory drugs.

Authors:  J H Lin; D M Cocchetto; D E Duggan
Journal:  Clin Pharmacokinet       Date:  1987-06       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs.

Authors:  R K Verbeeck; J L Blackburn; G R Loewen
Journal:  Clin Pharmacokinet       Date:  1983 Jul-Aug       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.